Merck Says Antiviral Pill for COVID-19 Is Effective, Plans to File for Emergency Authorization

The antiviral, molnupiravir, cut the risk of hospitalization or death in half for adults who were deemed at risk but not hospitalized, according to a planned interim analysis of the trial.

from Entrepreneur: Latest Articles The antiviral, molnupiravir, cut the risk of hospitalization or death in half for adults who were deemed at risk but not hospitalized, according to a planned interim analysis of the trial. https://ift.tt/eA8V8J October 02, 2021 at 12:07AMhttps://https://ift.tt/3uuI18E